Loading…
CIK 0001822947 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ally-bridge-group-ny-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $9.4M | 9.8% | 70,000 SH | New |
| ATAI BECKLEY NV | SHS | $7.0M | 7.3%Prev: 7.4% | 1,713,105 SH | Decreased-573,900 SH |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $7.6M | 7.9%Prev: 7.6% | 1,100,000 SH | Decreased-1,072,082 SH |
| EDGEWISE THERAPEUTICS INC | COM | $11.0M | 11.5% | 445,000 SH | New |
| EUPRAXIA PHARMACEUTICALS INC | COM | $3.0M | 3.1%Prev: 3.3% | 397,895 SH | Decreased-517,105 SH |
| INVENTIVA SA | ADS | $7.0M | 7.3% | 1,500,000 SH | New |
| MINERVA NEUROSCIENCES INC | COM NEW | $6.7M | 6.9% | 1,655,500 SH | New |
| OVID THERAPEUTICS INC | COM | $2.9M | 3.0% | 1,785,000 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $5.9M | 6.1%Prev: 3.2% | 19,882 SH | Increased-80,118 SH |
| PROMIS NEUROSCIENCES INC | COM SHS | $1.7M | 1.8% | 249,339 SH | New |
| REPLIMUNE GROUP INC | COM | $11.7M | 12.2%Prev: 9.2% | 1,200,000 SH | Decreased-2,400,000 SH |
| SOLENO THERAPEUTICS INC | COM | $7.8M | 8.1%Prev: 22.7% | 168,029 SH | Decreased-384,454 SH |
| SOLID BIOSCIENCES INC | COM NEW | $2.3M | 2.4%Prev: 2.1% | 413,625 SH | Decreased-135,557 SH |
| TAYSHA GENE THERAPIES INC | COM SHS | $5.3M | 5.5%Prev: 3.8% | 957,132 SH | Decreased-940,980 SH |
| UNIQURE NV | SHS | $4.8M | 5.0% | 200,000 SH | New |
| WHITEHAWK THERAPEUTICS INC | COM | $2.0M | 2.1%Prev: 0.9% | 817,939 SH | Increased |
| 13F-HR |
| 0001193125-26-352338 |
| $113.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008419 | $120.2M | View |
| May 18, 2026 | Q1 2026 | 13F-HR | 0001193125-26-227559 | $123.8M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005586 | $110.9M | View |